CHAOJU EYE CARE (02219) spent 312,700 Hong Kong dollars to repurchase 120,000 shares on November 28th.
Chaoju EyeCare (02219) announced that on November 28, 2025, the company repurchased 120,000 shares at a total cost of HKD 312,700, with a repurchase price of HKD 2.58-2.63 per share.
CHAOU EYE CARE (02219) announced on November 28, 2025, that the company will spend 312,700 Hong Kong dollars to repurchase 120,000 shares, with a repurchase price of 2.58-2.63 Hong Kong dollars per share.
Related Articles
ZHONGHUA GAS (08246) releases interim results, with a net loss attributable to shareholders of 13.454 million yuan, a decrease of 38.5% year-on-year.
IVD MEDICAL (01931) spent HKD 7.7236 million to repurchase 1.187 million shares on November 28th.
STARGLORY HLDGS (08213) announces interim results, with a net loss of HK$10.345 million, a decrease of 8.87% year-on-year.
ZHONGHUA GAS (08246) releases interim results, with a net loss attributable to shareholders of 13.454 million yuan, a decrease of 38.5% year-on-year.
IVD MEDICAL (01931) spent HKD 7.7236 million to repurchase 1.187 million shares on November 28th.
STARGLORY HLDGS (08213) announces interim results, with a net loss of HK$10.345 million, a decrease of 8.87% year-on-year.
RECOMMEND
Food Delivery Ceasefire: Chinese Concept Stocks Reach Dual Inflection In Value And Technology — From Cash‑Burning Rivalry To An AI‑Led Strategic Upgrade
27/11/2025
Six Departments Issue Joint Plan To Boost Consumption And Improve Supply‑Demand Alignment For Consumer Goods
27/11/2025
Citi Research On China’s Humanoid Robot Industry: Broad Optimism, Exponential Growth Likely In 2026, At Least A Doubling
27/11/2025
